Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia.

MLA

Aoki, Shuri, et al. “Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia.” Cancers, vol. 16, no. 3, Feb. 2024, p. 562. EBSCOhost, https://doi.org/10.3390/cancers16030562.

APA

Aoki, S., Ishikawa, H., Nakajima, M., Yamamoto, N., Mori, S., Omatsu, T., Tada, Y., Mizobuchi, T., Ikeda, S., Yoshino, I., & Yamada, S. (2024). Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia. Cancers, 16(3), 562. https://doi.org/10.3390/cancers16030562

Chicago

Aoki, Shuri, Hitoshi Ishikawa, Mio Nakajima, Naoyoshi Yamamoto, Shinichiro Mori, Tokuhiko Omatsu, Yuji Tada, et al. 2024. “Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia.” Cancers 16 (3): 562. doi:10.3390/cancers16030562.